Dang, Chi V.
Reddy, E. Premkumar
Shokat, Kevan M.
Soucek, Laura
Article History
First Online: 23 June 2017
Competing interests
: C.V.D. declares no competing interests. E.P.R. is the scientific founder, Board member and paid consultant of Onconova Therapeutics, Inc., which is developing rigosertib for cancer therapy. K.M.S. is an inventor on patents related to KRAS-G12C-targeting drugs licensed to Araxes Pharma. He is also a shareholder and consultant to Araxes Pharma. L.S. is founder and shareholder of Peptomyc S.L.